Variant report

Variant	esv3427846
Chromosome Location	chr21:44597783-44602181
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:28)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:28 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:44595975..44600241-chr21:44843202..44849395,11	MCF-7	breast:
2	chr21:44598282..44598954-chr21:44689291..44689941,2	MCF-7	breast:
3	chr12:45609823..45610333-chr21:44597019..44597949,2	Hela-S3	cervix:
4	chr21:44596353..44597867-chr21:44760877..44763023,2	MCF-7	breast:
5	chr21:44597096..44598685-chr21:44750362..44752904,2	MCF-7	breast:
6	chr21:44595798..44598770-chr21:45063265..45067849,4	MCF-7	breast:
7	chr21:44595418..44598407-chr21:45007465..45009708,2	MCF-7	breast:
8	chr21:44595103..44597994-chr21:45059971..45061669,2	MCF-7	breast:
9	chr21:44595703..44598660-chr21:45028207..45031192,2	MCF-7	breast:
10	chr21:44602074..44605807-chr21:44607173..44611012,3	MCF-7	breast:
11	chr21:44597050..44598895-chr21:44866871..44869287,2	MCF-7	breast:
12	chr21:44599423..44602035-chr21:44607332..44609772,2	MCF-7	breast:
13	chr21:44598660..44599239-chr21:44846133..44847235,3	MCF-7	breast:
14	chr21:44601256..44604083-chr21:44761290..44763384,2	MCF-7	breast:
15	chr21:44597633..44599530-chr21:44922531..44924601,2	MCF-7	breast:
16	chr21:44595907..44598227-chr21:44599190..44600855,2	MCF-7	breast:
17	chr21:44601367..44602903-chr21:44845535..44847208,2	MCF-7	breast:
18	chr21:44601197..44603306-chr21:44842721..44844263,2	MCF-7	breast:
19	chr21:44588285..44592993-chr21:44594253..44598657,5	MCF-7	breast:
20	chr21:44596809..44598374-chr21:45064063..45066950,2	K562	blood:
21	chr21:44596302..44600320-chr21:44763162..44765941,4	MCF-7	breast:
22	chr21:44595581..44597977-chr21:44722947..44725523,2	K562	blood:
23	chr21:44590676..44595436-chr21:44598084..44601687,4	K562	blood:
24	chr21:44597167..44598866-chr21:44766112..44768773,2	MCF-7	breast:
25	chr21:44588420..44591147-chr21:44596861..44598398,2	MCF-7	breast:
26	chr21:44596910..44599943-chr21:44921245..44924609,4	MCF-7	breast:
27	chr21:44595827..44599164-chr21:44845631..44847666,4	MCF-7	breast:
28	chr21:44595907..44598227-chr21:44599190..44600855,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000237864	chromatin interactions
ENSG00000177119	chromatin interactions
ENSG00000142178	chromatin interactions
ENSG00000160202	chromatin interactions
ENSG00000134297	chromatin interactions

Extended variants
information (count: 231 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:231 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183261852	chr21:44597839-44597840	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs34033606	chr21:44597899-44597900	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs567904011	chr21:44597900-44597901	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs147915149	chr21:44597910-44597911	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs187176902	chr21:44597914-44597915	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs557639884	chr21:44597930-44597931	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs575882394	chr21:44597935-44597936	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs191985751	chr21:44597966-44597967	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs111563569	chr21:44598002-44598003	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs528792276	chr21:44598011-44598012	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs369936621	chr21:44598034-44598035	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs374416050	chr21:44598038-44598039	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs143484248	chr21:44598049-44598050	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs559045024	chr21:44598056-44598057	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs532944134	chr21:44598082-44598083	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs544946113	chr21:44598161-44598162	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs563614586	chr21:44598163-44598164	Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs113279967	chr21:44598203-44598204	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs375343997	chr21:44598204-44598205	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs117520663	chr21:44598215-44598216	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs560795486	chr21:44598236-44598237	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs528556844	chr21:44598267-44598268	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs372091560	chr21:44598276-44598277	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs571505573	chr21:44598278-44598279	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs532535826	chr21:44598309-44598310	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs111715865	chr21:44598310-44598311	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs550961087	chr21:44598321-44598322	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs569558954	chr21:44598343-44598344	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs377671803	chr21:44598362-44598363	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs555189673	chr21:44598419-44598420	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs370972888	chr21:44598435-44598436	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs373948115	chr21:44598436-44598437	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs184587215	chr21:44598441-44598442	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs552298044	chr21:44598452-44598453	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs376541400	chr21:44598470-44598471	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs546755894	chr21:44598480-44598481	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs562972417	chr21:44598491-44598492	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs9975271	chr21:44598497-44598498	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs146458986	chr21:44598554-44598555	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs113660516	chr21:44598561-44598562	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs2839640	chr21:44598568-44598569	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs140969574	chr21:44598610-44598611	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs114388005	chr21:44598666-44598667	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs367592309	chr21:44598680-44598681	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs113525521	chr21:44598747-44598748	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs189189116	chr21:44598754-44598755	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs112704811	chr21:44598803-44598804	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs11701225	chr21:44598827-44598828	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs193240187	chr21:44598848-44598849	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs138717373	chr21:44598869-44598870	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Prostate cancer	18632612	CNVD
Neuroblastoma	20406844	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:237 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:44593800-44599000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
2	chr21:44593800-44599800	Enhancers	Placenta	Placenta
3	chr21:44593800-44601600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr21:44594000-44598200	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr21:44595600-44602400	Enhancers	Breast Myoepithelial Primary Cells	Breast
6	chr21:44596000-44597800	Enhancers	Fetal Brain Male	brain
7	chr21:44596400-44597800	Flanking Active TSS	Stomach Smooth Muscle	stomach
8	chr21:44596400-44598200	Enhancers	iPS-18 Cell Line	embryonic stem cell
9	chr21:44596400-44598200	Flanking Active TSS	Hela-S3	cervix
10	chr21:44596400-44598200	Enhancers	HSMMtube	muscle
11	chr21:44596400-44599400	Enhancers	Placenta Amnion	Placenta Amnion
12	chr21:44596400-44600400	Enhancers	Spleen	Spleen
13	chr21:44596600-44597800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
14	chr21:44596600-44597800	Enhancers	Brain Angular Gyrus	brain
15	chr21:44596600-44597800	Enhancers	Fetal Lung	lung
16	chr21:44596600-44598000	Enhancers	HUVEC	blood vessel
17	chr21:44596600-44598200	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
18	chr21:44596600-44598200	Enhancers	Brain Anterior Caudate	brain
19	chr21:44596600-44598400	Flanking Active TSS	Dnd41	blood
20	chr21:44596600-44599200	Enhancers	Left Ventricle	heart
21	chr21:44596600-44599400	Enhancers	NHLF	lung
22	chr21:44596600-44599600	Enhancers	NHEK	skin
23	chr21:44596600-44600800	Enhancers	Pancreas	Pancrea
24	chr21:44596600-44601600	Enhancers	HMEC	breast
25	chr21:44596800-44597800	Flanking Active TSS	Primary B cells from peripheral blood	blood
26	chr21:44596800-44597800	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
27	chr21:44596800-44597800	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
28	chr21:44596800-44597800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr21:44596800-44597800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
30	chr21:44596800-44597800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
31	chr21:44596800-44597800	Flanking Active TSS	Primary mononuclear cells fromperipheralblood	Blood
32	chr21:44596800-44597800	Flanking Active TSS	Colonic Mucosa	Colon
33	chr21:44596800-44597800	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
34	chr21:44596800-44597800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
35	chr21:44596800-44597800	Flanking Active TSS	A549	lung
36	chr21:44596800-44598000	Flanking Active TSS	Primary T cells fromperipheralblood	blood
37	chr21:44596800-44598000	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
38	chr21:44596800-44598000	Flanking Active TSS	Fetal Thymus	thymus
39	chr21:44596800-44598000	Flanking Active TSS	Thymus	Thymus
40	chr21:44596800-44598200	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr21:44596800-44598200	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
42	chr21:44596800-44598200	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
43	chr21:44596800-44598200	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
44	chr21:44596800-44598200	Flanking Active TSS	Adipose Nuclei	Adipose
45	chr21:44596800-44599200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr21:44596800-44602400	Enhancers	Cortex derived primary cultured neurospheres	brain
47	chr21:44597000-44597800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
48	chr21:44597000-44597800	Flanking Active TSS	Primary hematopoietic stem cells	blood
49	chr21:44597000-44597800	Flanking Active TSS	Fetal Muscle Leg	muscle
50	chr21:44597000-44598000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links